FLT3 and acute myeloid leukemia: In FLT3-ITD AML cells, NOX2 inhibitors have been reported to cause decreased intracellular concentrations of ROS, inhibiting FLT3’s growth and survival downstream pathways, and increasing apoptosis associated with restoration of p38MAPK and induction of mitochondrial ROS [67].